Flu vaccine strategy on the line as new US leaders anticipated to take charge
As countries in the Northern hemisphere deal with the flu season, experts say regulation surrounding flu vaccines could be due…
12 Dec 2024
How Pfizer management outplayed activist investor Starboard
Amidst dwindling share prices and widespread criticism, Pfizer CEO Albert Bourla appears to have withstood an attempted ousting by activist investor Starboard Value. On 6 October, Bourla received a blank…
28 Nov 2024
Trump 2.0 spells global change in pharmaceutical regulation, funding and investment
Having promised to “Make America Healthy Again”, the administration in Trump’s second presidency looks set to shake up the health sector – both domestically and internationally. Regulatory bodies, including the…
22 Nov 2024
Magazine: Pharma’s green shift with dry powder inhalers
Several pharmaceutical companies are advancing dry powder inhalers (DPIs) for respiratory conditions in an effort to cut down on greenhouse emissions and create a solution that is more eco-friendly than…
12 Nov 2024
Are dry powder inhalers the key to sustainable respiratory care?
In a bid to improve the pharma sector’s drive to cut down greenhouse emissions, several companies are advancing dry powder inhalers (DPIs) for respiratory conditions that are more eco-friendly than…
11 Nov 2024
How to adapt to choppy waters in biotech ecosystem
As the US enters a new political era, experts predict that the pharmaceutical and clinical trials industry will have to weather a changing ecosystem. There are promising signs of a…
05 Nov 2024
Injectables manufacturing ushers in a new era of accessibility
The pharmaceutical injectables market is gaining more traction as vaccines and the development of biological drugs such as cell and gene therapies grow. Multiple new therapy areas have emerged and…